Dr Andrew Jackson

Speciality: Oncology

Consultant Clinical Oncologist and Honorary Clinical Senior Lecturer

Sub-speciality

  • GI cancers, lung cancer, skin cancer

Other Responsibilties

  • Acute Oncology Lead, Hampshire Hospitals NHS FOundation Trust
  • Chair, Radiotherapy Group, Wessex Comprehensive Clinical Network (previously CSCCN)
  • Member of NCRI  CTRad (Clinical and Translational Radiotherapy Research Working Group) Workstream 2 (Phase II trials) 

Training and education

  • Undergraduate training 1989-1995 : University of Cambridge and St George’s Hospital Medical School
  • MRCP 1998
  • Oncology Training 1999-2006: pan-Thames training scheme
  • FRCR 2003, Rohan Williams medal
  • MD 2003-2005: Royal Marsden Hospital/Institute of Cancer Research

Experience

Dr Jackson has worked for the trust since October 2010.

He gained his CCST in Clinical Oncology in 2006 and took a post as a Clinical Lecturer and Hon. Consultant Oncologist at The University of Manchester/Christie Hospital specialising in upper GI cancers, with additional academic interests in Image Guided Radiotherapy (IGRT) and imaging.

In 2010 he moved to a post between North Hampshire Hospital Basingstoke and University Hospitals Southampton Trust.

He is continuing to pursue his research interest in upper GI cancers.

Key achievements

  • Principal Investigator, The BioStent Study: Biodegradable Oesophageal Stents and Radiotherapy for the Palliation of Dysphagia in Carcinoma of the Oesophagus. Awarded funding through NIHR Research for Patient Benefit funding stream 2012.
  • Principal Investigator, ROCOCO: Radiotherapy and Olaparib in Combination for Oesophageal Cancer. Phase 1 dose escalation study. Awarded funding by CRUK New Agents Committee January 2011
  • Principal investigator, Christie Hospital, Manchester: PACER (Locally Advanced pancreatic cancer: Phase II study of Cetuximab and 3-D conformal Image Guided Radiotherapy). Three centre NCRN badged study
  • Co-investigator, Christie Hospital, Manchester: ‘A real time visual feedback device for reducing patient movement during radiotherapy’, NIHR New and Emerging Applications of Technology (NEAT) award 2008
  • Principal investigator Christie Hospital, Manchester: DCE-MRI in oesophageal cancer: a pilot study. University of Manchester Magnetic Resonance Imaging Facility. 

 

Contact Dr Andrew Jackson

W3C AAA